
Sign up to save your podcasts
Or


In this episode, Dr Jamie Coleman is joined by Shayna Showalter, MD, from the University of Virginia School of Medicine, Charlottesville, VA. They discuss Dr Showalter’s recent study evaluating precision breast intraoperative radiation therapy (PB-IORT), which uses customized CT-based treatment plans for high-dose-rate (HDR) brachytherapy. Interim results show that PB-IORT has an acceptable breast cancer recurrence rate, minimal side effects, and excellent cosmetic outcomes.
Disclosure Information: Drs Coleman and Showalter have nothing to disclose.
To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.
Turkheimer, Lena M MD, MPH; Petroni, Gina R PhD; Berger, Adam C MD, FACS; Schroen, Anneke T MD, MPH, FACS; Brenin, David R MD, FACS; Lazar, Melissa MD, FACS; Libby, Bruce PhD; Janowski, Einsley M MD, PhD; Showalter, Timothy N MD, MPH; Showalter, Shayna L MD, FACS. Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical Trial. Journal of the American College of Surgeons 238(1):p 10-20, January 2024. | DOI: 10.1097/XCS.0000000000000869
Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.
#JACSOperativeWord
By The American College of Surgeons4.7
1313 ratings
In this episode, Dr Jamie Coleman is joined by Shayna Showalter, MD, from the University of Virginia School of Medicine, Charlottesville, VA. They discuss Dr Showalter’s recent study evaluating precision breast intraoperative radiation therapy (PB-IORT), which uses customized CT-based treatment plans for high-dose-rate (HDR) brachytherapy. Interim results show that PB-IORT has an acceptable breast cancer recurrence rate, minimal side effects, and excellent cosmetic outcomes.
Disclosure Information: Drs Coleman and Showalter have nothing to disclose.
To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.
Turkheimer, Lena M MD, MPH; Petroni, Gina R PhD; Berger, Adam C MD, FACS; Schroen, Anneke T MD, MPH, FACS; Brenin, David R MD, FACS; Lazar, Melissa MD, FACS; Libby, Bruce PhD; Janowski, Einsley M MD, PhD; Showalter, Timothy N MD, MPH; Showalter, Shayna L MD, FACS. Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical Trial. Journal of the American College of Surgeons 238(1):p 10-20, January 2024. | DOI: 10.1097/XCS.0000000000000869
Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.
#JACSOperativeWord

1,306 Listeners

15,629 Listeners

29,219 Listeners